Clinical trial
Multihance Versus Magnevist in Breast MRI
NCT00486473 · Bracco Diagnostics, Inc, Industry · Completed
Key facts
| NCT number | NCT00486473 |
|---|---|
| Title | Multihance Versus Magnevist in Breast MRI |
| Official title | Phase III Multicenter Double-Blind, Randomized, Crossover Study to Compare MultiHance With Magnevist in Contrast-enhanced Magnetic Resonance Imaging (MRI) of the Breast |
| Acronym | DETECT |
| Lead sponsor | Bracco Diagnostics, Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Multihance, Magnevist |
| Enrollment | 130 |
| Start date | Jul 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jun 14, 2007 |
| Last update posted | Jul 15, 2010 |
| Countries | Italy |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: